Cite
HARVARD Citation
Min, T. et al. (2017). Dapagliflozin and renal function. Re: Diabetes and kidney disease: the role of sodium–glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes. Mende CW. Curr Med Res Opin 2017;33:541-551. Current medical research and opinion. pp. 1715-1716. [Online].